BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30036220)

  • 1. Use of a Sentinel Lymph Node Biopsy Algorithm in a South African Population of Patients With Cervical Cancer and High Prevalence of Human Immunodeficiency Virus Infection.
    Snyman LC; Bryant EP; Wethmar EI; de Greve T; Reyneke F; Sathekge MM; Lindeque BG; Abu-Rustum NR
    Int J Gynecol Cancer; 2018 Sep; 28(7):1432-1437. PubMed ID: 30036220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining Indocyanine Green and Tc
    Lührs O; Ekdahl L; Lönnerfors C; Geppert B; Persson J
    Gynecol Oncol; 2020 Feb; 156(2):335-340. PubMed ID: 31780237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.
    Salvo G; Ramirez PT; Levenback CF; Munsell MF; Euscher ED; Soliman PT; Frumovitz M
    Gynecol Oncol; 2017 Apr; 145(1):96-101. PubMed ID: 28188015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99m-indocyanine green versus technetium-99m-methylene blue for sentinel lymph node biopsy in early-stage endometrial cancer.
    Cabrera S; Bebia V; Franco-Camps S; Forcada C; Villasboas-Rosciolesi D; Navales I; Pérez-Benavente A; Gil-Moreno A
    Int J Gynecol Cancer; 2020 Mar; 30(3):311-317. PubMed ID: 31992599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer (99m)Tc and/or Blue Dye.
    Buda A; Crivellaro C; Elisei F; Di Martino G; Guerra L; De Ponti E; Cuzzocrea M; Giuliani D; Sina F; Magni S; Landoni C; Milani R
    Ann Surg Oncol; 2016 Jul; 23(7):2183-91. PubMed ID: 26714944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymphadenectomy in cervical cancer using near infrared fluorescence from indocyanine green combined with technetium-99m-nanocolloid.
    Soergel P; Kirschke J; Klapdor R; Derlin T; Hillemanns P; Hertel H
    Lasers Surg Med; 2018 Dec; 50(10):994-1001. PubMed ID: 29968916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-Time Fluorescent Sentinel Lymph Node Mapping with Indocyanine Green in Women with Previous Conization Undergoing Laparoscopic Surgery for Early Invasive Cervical Cancer: Comparison with Radiotracer ± Blue Dye.
    Buda A; Papadia A; Di Martino G; Imboden S; Bussi B; Guerra L; De Ponti E; Reato C; Gasparri ML; Crivellaro C; Mueller M
    J Minim Invasive Gynecol; 2018; 25(3):455-460. PubMed ID: 29032256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of ICG-
    Paredes P; Vidal-Sicart S; Campos F; Tapias A; Sánchez N; Martínez S; Carballo L; Pahisa J; Torné A; Ordi J; Carmona F; Lomeña F
    Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1853-1861. PubMed ID: 28492965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The detection of sentinel lymph nodes in laparoscopic surgery for uterine cervical cancer using 99m-technetium-tin colloid, indocyanine green, and blue dye.
    Tanaka T; Terai Y; Ashihara K; Tsunetoh S; Akagi H; Yamada T; Ohmichi M
    J Gynecol Oncol; 2017 Mar; 28(2):e13. PubMed ID: 27894166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm).
    Di Martino G; Crivellaro C; De Ponti E; Bussi B; Papadia A; Zapardiel I; Vizza E; Elisei F; Diestro MD; Locatelli L; Gasparri ML; Di Lorenzo P; Mueller M; Buda A
    J Minim Invasive Gynecol; 2017; 24(6):954-959. PubMed ID: 28571944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer.
    Kim JH; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    World J Surg Oncol; 2018 Mar; 16(1):52. PubMed ID: 29523141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
    Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
    Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indocyanine green versus technetium-99m with blue dye for sentinel lymph node detection in early-stage cervical cancer: A systematic review and meta-analysis.
    Baeten IGT; Hoogendam JP; Jeremiasse B; Braat AJAT; Veldhuis WB; Jonges GN; Jürgenliemk-Schulz IM; van Gils CH; Zweemer RP; Gerestein CG
    Cancer Rep (Hoboken); 2022 Jan; 5(1):e1401. PubMed ID: 33973745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel Node Mapping Using Indocyanine Green and Near-infrared Fluorescence Imaging Technology for Uterine Malignancies: Preliminary Experience With the Da Vinci Xi System.
    Siesto G; Romano F; Fiamengo B; Vitobello D
    J Minim Invasive Gynecol; 2016; 23(4):470-1. PubMed ID: 26767824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resection of the upper paracervical lymphovascular tissue should be an integral part of a pelvic sentinel lymph node algorithm in early stage cervical cancer.
    Lührs O; Ekdahl L; Geppert B; Lönnerfors C; Persson J
    Gynecol Oncol; 2021 Nov; 163(2):289-293. PubMed ID: 34509298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Near-infrared fluorescence imaging compared to standard sentinel lymph node detection with blue dye in patients with vulvar cancer - a randomized controlled trial.
    Deken MM; van Doorn HC; Verver D; Boogerd LSF; de Valk KS; Rietbergen DDD; van Poelgeest MIE; de Kroon CD; Beltman JJ; van Leeuwen FWB; Putter H; Braak JPBM; de Geus-Oei LF; van de Velde CJH; Burggraaf J; Vahrmeijer AL; Gaarenstroom KN
    Gynecol Oncol; 2020 Dec; 159(3):672-680. PubMed ID: 33041071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescent Indocyanine Green versus Technetium-99m and Blue Dye for Bilateral SENTinel Lymph Node Detection in Stage I-IIA Cervical Cancer (FluoreSENT): protocol for a non-inferiority study.
    Baeten IGT; Hoogendam JP; Braat AJAT; Veldhuis WB; Jonges GN; Jürgenliemk-Schulz IM; Zweemer RP; Gerestein CG
    BMJ Open; 2022 Sep; 12(9):e061829. PubMed ID: 36100304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A hybrid radioactive and fluorescence approach is more than the sum of its parts; outcome of a phase II randomized sentinel node trial in prostate cancer patients.
    Wit EMK; KleinJan GH; Berrens AC; van Vliet R; van Leeuwen PJ; Buckle T; Donswijk ML; Bekers EM; van Leeuwen FWB; van der Poel HG
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2861-2871. PubMed ID: 37036490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel Node Biopsy in Endometrial Cancer With Dual Cervical and Fundal Indocyanine Green Injection.
    Ruiz R; Gorostidi M; Jaunarena I; Goiri C; Aguerre J; Lekuona A
    Int J Gynecol Cancer; 2018 Jan; 28(1):139-144. PubMed ID: 29194192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study.
    Guo J; Yang H; Wang S; Cao Y; Liu M; Xie F; Liu P; Zhou B; Tong F; Cheng L; Liu H; Wang S
    World J Surg Oncol; 2017 Nov; 15(1):196. PubMed ID: 29096643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.